[ad_1]
NEW YORK/WASHINGTON (Reuters) – U.S. President Donald Trump on Monday took aim at Pfizer Inc (PFE.N) and other U.S. drugmakers just after they lifted price ranges on some of their medications on July 1, saying his administration would act in response.
“Pfizer & some others should really be ashamed that they have raised drug price ranges for no cause.” Trump wrote in a publish on Twitter on Monday. “We will respond!”
Trump had reported in May that some drug organizations would soon announce “voluntary, significant” cuts in price ranges, but none have materialized but. During his presidential campaign, he promised decrease U.S. drug charges.
Pfizer elevated record price ranges on all around 40 medications earlier this thirty day period. Those people include Viagra, cholesterol drug Lipitor and arthritis therapy Xeljanz, according to Wells Fargo. Checklist prices do not involve rebates and discount rates drugmakers may supply.
“The record cost stays unchanged for the the greater part of our medicines. Our portfolio features additional than 400 medicines and vaccines. We are modifying selling prices for roughly 10 % of these, together with some occasions where by we’re reducing the selling price,” Pfizer spokeswoman Sally Beatty explained to Reuters.
(Reporting by Michael Erman and Susan Heavey Editing by David Gregorio)
[ad_2]
Supply link